SurgLine International, Inc.

SurgLine International, Inc.

SGLN
SurgLine International, Inc.US flagOther OTC
0.00
USD
- -
- -
569,012.00Market Cap
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
TTM
Revenue per Share
3.2
1.75
0.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.14
0.06
-0.34
-0.19
-0.01
-0.02
0.01
-0.01
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.05
0.05
-0.05
-0.03
- -
-0.01
-0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.05
-0.12
-0.39
-0.48
-0.01
-0.04
0.01
-0.05
-0.05
-0.04
-0.03
- -
- -
Tangible Book Value per Share
- -
0.01
-0.21
-0.28
-0.09
-0.1
-0.02
-0.01
-0.01
-0.01
- -
- -
- -
Basic Weighted Avg Shares
2
5
10
14
46
50
55
201
215
326
483
- -
5,386
Sales/Revenue/Turnover
6
8
6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
0.95
7.55
-16.73
- -
-727.05
-1,806.22
- -
-19,453.3
-16,329.82
- -
- -
-1,832.45
-1,832.45
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-3
-3
- -
-1
- -
-1
-1
-1
- -
-3
-3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-4.26
3.42
-56.92
- -
-557.19
-2,160.81
- -
-19,851.95
-24,859.44
- -
- -
-2,409.35
-2,409.35
Working Capital
- -
-1
-3
-4
-4
-5
-1
-2
-2
-2
-2
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
-2
-4
-4
-5
-1
-1
-2
-2
-2
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jan'12
Apr'12
Jul'12
ST Debt
1
1
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5,897
5,012
5,480
Market Capitalization
6
2
3

Working Capital

FRC

in mil. unless spec.
Jan'12
Apr'12
Jul'12
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
1
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-327.14%
17.31%
-5.18%
Free Cash Flow
-108.03%
8.11%
123.83%
Net Income, GAAP
-124.67%
29.78%
792.5%
Sales/Revenue/Turnover
- -
- -
3,488.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Thomas G. Toland
Sector
Industrials
Industry
Electrical Equipment & Parts
Address
319 Clematis Street West Palm Beach FL United States of America
IPO Date
Sep 2, 2011
Business
SurgLine International, Inc. (SGLN) sources and sells medical and surgical products at discount prices, primarily through its wholly owned subsidiary SurgLine Inc., offering surgical implants, spine hardware such as cervical PEEK interbody fusion devices, anterior/posterior and transformal lumbar interbody fusion systems, trauma products, surgical sets including trays/instruments/screws/implants, surgical instruments like scissors/forceps/basket punches/saw blades/reamers/pulse lavage, drill systems/power tools comprising cordless/pneumatic drills/chucks/sleeves/saws/hoes/chargers/batteries, as well as medical/dental/surgical disposables and single-use supplies used by physicians, dentists, and healthcare providers. The company, founded in 1996 and headquartered at 319 Clematis Street, Suite 400, West Palm Beach, Florida, operates as a development-stage holding company targeting institutional buyers and stocking distributors via its website www.surglinesupplies.com, with a focus on the U.S. healthcare market including spine, trauma, and sports medicine segments. It is also developing a physician office allergy testing program using sublingual immunotherapy (SLIT); however, no major recent partnerships, acquisitions, funding rounds, product launches, or strategic expansions have been reported in the last 1-2 years, with the last notable activities including a 2012 agreement to supply spinal implants in California and earlier trauma product line growth via acquisition.